Gilead Sciences Inc. (GILD)

74.40
1.14 1.56
NASDAQ : Health Technology
Prev Close 73.26
Open 74.38
Day Low/High 73.36 / 74.55
52 Wk Low/High 60.89 / 85.97
Volume 12.51M
Avg Volume 22.29M
Exchange NASDAQ
Shares Outstanding 1.25B
Market Cap 94.25B
EPS 4.20
P/E Ratio 19.27
Div & Yield 2.72 (3.30%)

Today's Takeaways and Observations (Afternoon Edition)

"How does it feel, how does it feel? To be without a home Like a complete unknown, like a rolling stone." -- Bob Dylan, Like A Rolling Stone  "The Edifice Complex."   The message of the bond market is clear -- slowing inflation, economic growth and ...

The Good, the Bad and the Ugly (Boring Edition)

"There are two kinds of spurs, my friend. Those that come in by the door; those that come in by the window.." -- Tuco, " The Good, the Bad and the Ugly" No "Takeaways" today as the action was kinda boring, uneventful and with little individual stock...

Some 'Value Traps' I See

"A value trap is a stock that appears to be cheap because the stock has been trading at low multiples of earnings, cash flow or book value for an extended time period. Stock traps attract investors who are looking for a bargain because these stocks ...

Takeaways and Observations

"She's a witch of trouble in electric blue, In her own mad mind she's in love with you. With you. Now what you gonna do? Strange brew, kill what's inside of you." -- Cream, Strange Brew     Strange brew!    You have probably forgotten October, 1987....

Added to Allergan on Weakness

Allergan , a day ahead of its earnings release, is down by over $4 on no apparent news, save a rotation out of biotech. (iShares Nasdaq Biotechnology is -3% or -$7 and we see individual equity declines in Celgene , Gilead , Acadia Pharmaceuticals , ...

The Good, the Bad and the Ugly (Late Afternoon Edition)

"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as I have I might be trading some of the earnings reports that will be released ...

Earnings: Assessing 3 Biotech Bellwethers

Earnings: Assessing 3 Biotech Bellwethers

How did Celgene, AbbVie and Gilead fare last quarter?

Trader's Daily Notebook: Market Could Use Jolt From Fed, Earnings

Trader's Daily Notebook: Market Could Use Jolt From Fed, Earnings

Nearly anything associated with oil and gas drilling gets crushed.

First Solar, NetApp, Gilead Could Profit Most on Trump's Tax Plan

First Solar, NetApp, Gilead Could Profit Most on Trump's Tax Plan

Apple isn't the biggest winner from Trump's plans for a tax holiday. These three stocks are...

Surveying the NASH Drug Landscape

Surveying the NASH Drug Landscape

Biotech investors should keep a close eye on the progress in this huge potential market.

The Good, the Bad and the Ugly (Mid-Afternoon Edition)

"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as I have to prepare for my Tulane trip. So let's move to the abbreviated Monarc...

Takeaways and Observations (3PM Edition)

I started the day with an important piece on bonds - at least I hope so. Sell 'em, short 'em!    Trade of the Week - long TBT (consistent with above).  Well off the opening, at $37.60 now - and that's a good thing.   So far, so good.  At 230PM yield...

The Good, the Bad and the Ugly (EarlyAfternoon Edition)

"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as I want to spend some time with my family right after the close. So let's move...

Takeaways and Observations: Second Quarter Start

"I would say that (today) the averages are faring better than the average stock -- on average. If you know what I mean!" --  Kass Diary, Consider this Yogiism!   With opening day yesterday and tonite's NCAA final (I like North Carolina in a high sin...

The Good, the Bad and the Ugly (2:00 p.m. Edition)

"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, "The Good, the Bad and the Ugly" Its been a long week, so there will be no "Takeaways." Let's move to the abbreviated Monarch Notes for...

Takeaways And Observations

For the first time in six years the DJIA fell for the eighth consecutive day. That said the Nasdaq has risen in ten of the last thirteen trading sessions as Donald Trump may be making volatility and uncertainty great again. (For that divergence and ...

The Good, the Bad and the Ugly (Early Afternoon Edition) 

FEB 27, 2017 ' 3:13 PM EST "You see, in this world there's two kinds of people, my friend: Those with loaded guns and those who dig. You dig." -- Blondie, "The Good, the Bad and the Ugly"   As I will shortly be leaving, there will be no "Takeaways."...

Takeaways & Observations

Risk happens fast.  Most don't short and shouldn't short -- it's a game that requires volumes of risk control.  However, I would continue to maintain well above-average cash positions.  Today was not a benign event, in my view.  Nor was it likely a ...

Takeaways & Observations (Early Afternoon Edition)

James Comey has the market comatose.  A contrary view on financials.  A contrary view on automobiles.  Deutsche Bank ? Not!  Very little trading today -- though I did add modestly to the short side.  Up, down ... and stayed down -- but not materiall...

Health Care Putting in a Base

Healthcare stocks had a heckuva four-year period of over-performance that ended in the summer of 2015. Since then the Health Care Select Sector SPDR ETF (40% pharma and 15% biotech) has had a series of trading-range moves as sector prices lagged. La...

Egalet Makes Friday's Biotech Mailbag

Egalet Makes Friday's Biotech Mailbag

Why the name is sagging, and what it will take to spur the sector higher.

4 Value Stock Picks for an Elevated Market

4 Value Stock Picks for an Elevated Market

Taking from Ben Graham's playbook, this handful of stocks have reasonable valuations in an extended market.

Takeaways & Observations

This is a great invite, "Wall Street Goes to Washington," in which legendary journalist Michael Wolff will sit down with my pal, The Mooch! And it's free!  Happy eighth anniversary, Mr. Market. My Generational Low call on The Kudlow Report was the b...

Takeaways and Observations

  "Wishin' and hopin' And thinkin' and prayin'..."  -- Dusty Springfield, Wishin' and Hopin'  The gap from last week's presidential speech was filled this afternoon.  I am more negative than most and more negative than I have been in a while.  Liter...

Midday Musings

 Nice move off of the lows for Allergan . (More than +$3 for the homegamers!) My Generational Bottom in Bond Yields (last July) looks very much intact. Two basis points higher in yield today Today's three-year US note auction was soft. This is not s...

Takeaways and Observations

Perhaps we can make a parallel between the S&P Index and Snap . Today SNAP just fell (by nearly 15%), maybe the S&P will follow! Hey, a guy can hope.  After all, the irrational might now be rationalized. And here is how some hedge fund icons feel ab...

Your Burning Biotech Questions Answered

Your Burning Biotech Questions Answered

We explore whether the biotech rally can continue and if Gilead Sciences has bottomed.

Your Burning Biotech Questions Answered

Your Burning Biotech Questions Answered

We explore whether the biotech rally can continue and if Gilead Sciences has bottomed.

Takeaways and Observations

I started the day with a discussion of the new administration's policies and why I believe there are headwinds to their passage over the next few months or quarters.  I covered last evening's Procter & Gamble short for a profit.  "For Traders Only."...

Cramer: If You Think I'm Drinking the Kool-Aid, Swallow This

Cramer: If You Think I'm Drinking the Kool-Aid, Swallow This

Some tried-and-true indicators show what's really going on with the market.